|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
on1014000386 |
003 |
OCoLC |
005 |
20240809213013.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
171129t20182018nju ob 001 0 eng |
010 |
|
|
|a 2017057426
|
040 |
|
|
|a DLC
|b eng
|e rda
|e pn
|c DLC
|d OCLCO
|d OCLCA
|d N$T
|d EBLCP
|d N$T
|d DG1
|d OCLCF
|d MERER
|d OCLCO
|d OCLCQ
|d UAB
|d OCLCO
|d OCLCQ
|d UPM
|d OCLCO
|d YDX
|d OCLCQ
|d STF
|d COO
|d OCLCQ
|d CHVBK
|d OCLCQ
|d CASUM
|d AU@
|d OCLCO
|d WYU
|d OCLCO
|d OCLCA
|d U3W
|d OCLCO
|d OCLCA
|d OCLCQ
|d YDX
|d OCLCO
|d OCLCQ
|d UKAHL
|d OCLCQ
|d SFB
|d OCLCQ
|d OCLCA
|d OCLCQ
|d UX1
|d K6U
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|
019 |
|
|
|a 1023526120
|a 1050744060
|a 1100433620
|a 1175623107
|
020 |
|
|
|a 9781118684504
|q (electronic book)
|
020 |
|
|
|a 1118684508
|q (electronic book)
|
020 |
|
|
|a 9781118684535
|q (electronic book)
|
020 |
|
|
|a 1118684532
|q (electronic book)
|
020 |
|
|
|z 9781118684528
|
020 |
|
|
|z 1118684524
|
020 |
|
|
|z 9781118123225
|q (hardcover)
|
020 |
|
|
|z 1118123220
|
035 |
|
|
|a (OCoLC)1014000386
|z (OCoLC)1023526120
|z (OCoLC)1050744060
|z (OCoLC)1100433620
|z (OCoLC)1175623107
|
042 |
|
|
|a pcc
|
050 |
1 |
4 |
|a RC271.I45
|b I46 2018
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
049 |
|
|
|a HCDD
|
245 |
0 |
0 |
|a Immunotherapy in translational cancer research /
|c edited by Laurence J.N. Cooper, Elizabeth A. Mittendorf, Judy Moyes, Sabitha Prabhakaran.
|
264 |
|
1 |
|a Hoboken, NJ :
|b John Wiley & Sons, Inc.,
|c 2018.
|
264 |
|
4 |
|c ©2018
|
300 |
|
|
|a 1 online resource
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Translational oncology
|
504 |
|
|
|a Includes bibliographical references and index.
|
520 |
|
|
|a "Immunotherapy in Translational Cancer Research is a volume in Translational Oncology, an exciting book series that focuses on translational cancer research. Immunotherapy has become a key aspect in the treatment of a wide variety of cancers, and this book is specifically designed for physicians, clinical fellows, medical students, graduate students, scientists, pharmaceutical executives, public health and public policy government leaders and community oncologists. Each chapter is consistently organized and features three essential themes: Development of the immunotherapy; Hurdles that were overcome to scale up and undertake clinical trials; and Clinical experience and application of research. Concepts, examples and alternative strategies to achieve individualized targeted therapy are presented, with thorough consideration of the relevant history, current state and future directions of emerging cancer-fighting therapies, drug development, clinical trials, and governmental resources and regulatory issues."--Provided by publisher.
|
588 |
0 |
|
|a Online resource; title from digital title page (viewed on March 11, 2019).
|
505 |
0 |
|
|a Translation in immunology: the role of translational biomarkers to guide clinical use of immunotherapy for cancer -- Monoclonal antibody therapy -- Somatic mutations and immunotherapy -- Checkpoint blockade -- Myeloid leukemia vaccines -- Cancer vaccines for solid tumors -- Immunotherapy with non-genetically modified T cells -- Immunotherapy with genetically modified T cells -- Immunomodulation with adjuvants and cytokines -- Immune cell migration in cancer and immunotherapy -- Repurposing of drugs for immunotherapy -- Immunomodulation with radiation -- Good manufacturing practices facilities for cellular therapy -- T cell receptor mimic anitbodies -- Stem cell transplantation for treatment of malignancy -- Natural killer cell-based immunotherapy -- Immunologic monitoring in immuno-oncology -- Cell-based therapies for canine cancer -- Interaction between targeted therapy and immunotherapy.
|
650 |
|
0 |
|a Cancer
|x Immunotherapy.
|
650 |
|
0 |
|a Immunotherapy.
|
650 |
|
0 |
|a Cancer
|x Immunological aspects.
|
650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
650 |
|
7 |
|a Cancer
|x Immunological aspects
|2 fast
|
650 |
|
7 |
|a Cancer
|x Immunotherapy
|2 fast
|
650 |
|
7 |
|a Immunotherapy
|2 fast
|
700 |
1 |
|
|a Cooper, Laurence J. N.,
|e editor.
|
700 |
1 |
|
|a Mittendorf, Elizabeth A.,
|e editor.
|
700 |
1 |
|
|a Moyes, Judy,
|d 1953-
|e editor.
|
700 |
1 |
|
|a Prabhakaran, Sabitha,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Immunotherapy in translational cancer research.
|d Hoboken, NJ : Wiley, 2018
|z 9781118123225
|w (DLC) 2017056123
|
830 |
|
0 |
|a Translational oncology (Series)
|
856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=5287418
|y Click for online access
|
903 |
|
|
|a EBC-AC
|
994 |
|
|
|a 92
|b HCD
|